CORT — Corcept Therapeutics Incorporated Share News
0.000.00%
Last trade - 00:00- $12.26bn
- $11.94bn
- $761.41m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
Corcept Therapeutics misses Q4 revenue expectations, net income drops 21%
Brief: Corcept Therapeutics Q4 EPS USD 0.2
Brief: Corcept Says US Court Rules Teva's Generic Korlym Does Not Infringe Corcept Patents
NASDAQ RESUMED AT 10:41 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:36 AM
NASDAQ RESUMED AT 10:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:31 AM
NASDAQ RESUMED AT 10:31 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM
U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer
U.S. STOCKS ON THE MOVE-Charter Communications, Western Digital, Regeneron
Corcept shares tumble after FDA letter reveals warnings before drug rejection
U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology
Corcept tumbles after FDA rejection letter reveals repeated warnings
U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel
U.S. STOCKS ON THE MOVE-Autodesk, Teledyne, Alphabet
U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital
Corcept's cancer drug cuts risk of death in ovarian cancer trial (updated)